Balgopal Commercial Schedules Q2 FY27 Results Board Meeting

Balgopal Commercial Ltd has scheduled a board meeting at 1:00 PM on 13 November 2026 to consider and take on record unaudited standalone and consolidated results for the quarter and half-year ended 30 September 2026, covering Q2 FY27 and the first half of FY27.

When will Balgopal Commercial consider its Q2 FY27 results?

Balgopal Commercial will hold its board meeting on Friday, 13 November 2026, at 1:00 PM. The company disclosed the meeting schedule through an intimation dated 4 November 2026.

The meeting is listed as a quarterly-results event in the company’s disclosed meeting calendar. Its stated purpose is the consideration and approval of unaudited financial statements for the three months and six months ended 30 September 2026.

The disclosure was signed by Ankit Ladha, Company Secretary and Compliance Officer. It also states that the board may consider other matters as it decides during the meeting, but no further agenda item was specifically disclosed.

What is on the board meeting agenda?

Balgopal Commercial’s board is scheduled to approve and take on record both standalone and consolidated unaudited financial results for Q2 FY27 and H1 FY27. The standalone statements relate to the company’s own operations, while consolidated statements include results required to be presented on a group basis.

The quarter under review ended on 30 September 2026. The half-year period covers 1 April 2026 to 30 September 2026, making this announcement important for investors tracking the company’s financial performance during the first half of the financial year.

The board had earlier met on 11 August 2026 to consider financial results for the quarter ended 30 June 2026. Its disclosed corporate calendar also records an annual general meeting on 4 September 2026 and an audited-results meeting on 22 May 2026.

What financial information has been reported for Q2 FY27?

The provided financial information for Q2 FY27 shows revenue or other income as nil and total expenses of ₹0.013 crore. It also reports a net loss of ₹0.013 crore for the quarter.

For comparison, total expenses were reported at ₹0.042 crore in Q1 FY27 and ₹0.0363 crore in Q2 FY26. The figures point to a reduction in the disclosed expense base compared with both reference periods, while income remained nil in the stated Q2 FY27 data.

The article data also refers to Balgopal Commercial’s Q1 FY27 net profit of ₹5.1 crore, up 200.0% year-on-year. However, investors should distinguish this reported Q1 figure from the Q2 FY27 board-meeting agenda, which concerns the results for the period ended 30 September 2026.

Why does the Q2 FY27 board meeting matter to investors?

The Q2 FY27 result review matters because it will place the company’s first-half financial position before the market. For a micro-cap company in the trading and distributors industry, the movement in income, expenses, profit or loss, and cash generation can be material to the assessment of operating performance.

The supplied data indicates nil revenue or other income for Q2 FY27 alongside a ₹0.013 crore net loss. The board’s formal consideration of standalone and consolidated statements is therefore the key event through which the market can assess the final reported numbers and any accompanying disclosures.

Earlier supplied information on the company’s Q2 FY26 performance had indicated revenue from operations of ₹0.0 crore and a net profit of ₹5.15 crore. It also cited profit before tax of ₹6.03 crore and EBITDA of ₹8 crore for that period. These numbers reflect a different reporting period and should not be treated as Q2 FY27 results.

How does the announcement fit Balgopal Commercial’s reporting cycle?

Balgopal Commercial’s 13 November meeting follows its regular financial-reporting sequence. The company had scheduled a board meeting on 11 August 2026 for results for the quarter ended 30 June 2026, followed by its annual general meeting in September.

The 13 November meeting is the next disclosed results milestone, focused on the September quarter and the first six months of FY27. The company has not disclosed any forward guidance, business target, dividend proposal, or capital-allocation decision in the meeting intimation.

For shareholders, the immediate focus will be the unaudited results approved by the board and any notes issued with them. The disclosed agenda does not establish an expected earnings outcome, beyond confirming that the relevant financial statements will be considered.

Conclusion

Balgopal Commercial has fixed 13 November 2026 at 1:00 PM for its board to consider unaudited standalone and consolidated Q2 FY27 and H1 FY27 financial results. The meeting is the company’s formal reporting event for the quarter and half-year ended 30 September 2026, with supplied Q2 FY27 data showing nil income and a ₹0.013 crore net loss.

Investors should watch for the board-approved results and related disclosures after the meeting, particularly the final income, expense, profit or loss and consolidated figures. The company’s notice identifies no separate strategic proposal or financial target beyond the results agenda.